414 related articles for article (PubMed ID: 25239307)
1. The lipid flippase heterodimer ATP8B1-CDC50A is essential for surface expression of the apical sodium-dependent bile acid transporter (SLC10A2/ASBT) in intestinal Caco-2 cells.
van der Mark VA; de Waart DR; Ho-Mok KS; Tabbers MM; Voogt HW; Oude Elferink RP; Knisely AS; Paulusma CC
Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2378-86. PubMed ID: 25239307
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of progressive familial intrahepatic cholestasis type 1 and benign recurrent intrahepatic cholestasis type 1 mutations on canalicular localization of ATP8B1.
Folmer DE; van der Mark VA; Ho-Mok KS; Oude Elferink RP; Paulusma CC
Hepatology; 2009 Nov; 50(5):1597-605. PubMed ID: 19731236
[TBL] [Abstract][Full Text] [Related]
3. Intestinal bile salt absorption in Atp8b1 deficient mice.
Groen A; Kunne C; Paulusma CC; Kramer W; Agellon LB; Bull LN; Oude Elferink RP
J Hepatol; 2007 Jul; 47(1):114-22. PubMed ID: 17448567
[TBL] [Abstract][Full Text] [Related]
4. Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport.
Paulusma CC; Groen A; Kunne C; Ho-Mok KS; Spijkerboer AL; Rudi de Waart D; Hoek FJ; Vreeling H; Hoeben KA; van Marle J; Pawlikowska L; Bull LN; Hofmann AF; Knisely AS; Oude Elferink RP
Hepatology; 2006 Jul; 44(1):195-204. PubMed ID: 16799980
[TBL] [Abstract][Full Text] [Related]
5. A flippase-independent function of ATP8B1, the protein affected in familial intrahepatic cholestasis type 1, is required for apical protein expression and microvillus formation in polarized epithelial cells.
Verhulst PM; van der Velden LM; Oorschot V; van Faassen EE; Klumperman J; Houwen RH; Pomorski TG; Holthuis JC; Klomp LW
Hepatology; 2010 Jun; 51(6):2049-60. PubMed ID: 20512993
[TBL] [Abstract][Full Text] [Related]
6. The phospholipid flippase ATP8B1 mediates apical localization of the cystic fibrosis transmembrane regulator.
van der Mark VA; de Jonge HR; Chang JC; Ho-Mok KS; Duijst S; Vidović D; Carlon MS; Oude Elferink RP; Paulusma CC
Biochim Biophys Acta; 2016 Sep; 1863(9):2280-8. PubMed ID: 27301931
[TBL] [Abstract][Full Text] [Related]
7. Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity.
Chen F; Ananthanarayanan M; Emre S; Neimark E; Bull LN; Knisely AS; Strautnieks SS; Thompson RJ; Magid MS; Gordon R; Balasubramanian N; Suchy FJ; Shneider BL
Gastroenterology; 2004 Mar; 126(3):756-64. PubMed ID: 14988830
[TBL] [Abstract][Full Text] [Related]
8. Taurocholate transport by hepatic and intestinal bile acid transporters is independent of FIC1 overexpression in Madin-Darby canine kidney cells.
Harris MJ; Kagawa T; Dawson PA; Arias IM
J Gastroenterol Hepatol; 2004 Jul; 19(7):819-25. PubMed ID: 15209631
[TBL] [Abstract][Full Text] [Related]
9. ATP8B1 deficiency disrupts the bile canalicular membrane bilayer structure in hepatocytes, but FXR expression and activity are maintained.
Cai SY; Gautam S; Nguyen T; Soroka CJ; Rahner C; Boyer JL
Gastroenterology; 2009 Mar; 136(3):1060-9. PubMed ID: 19027009
[TBL] [Abstract][Full Text] [Related]
10. The SLC10 carrier family: transport functions and molecular structure.
Döring B; Lütteke T; Geyer J; Petzinger E
Curr Top Membr; 2012; 70():105-68. PubMed ID: 23177985
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of genetic variants in the apical sodium-dependent bile acid transporter (ASBT; SLC10A2).
Ho RH; Leake BF; Urquhart BL; Gregor JC; Dawson PA; Kim RB
J Gastroenterol Hepatol; 2011 Dec; 26(12):1740-8. PubMed ID: 21649730
[TBL] [Abstract][Full Text] [Related]
12. Altered hepatobiliary gene expressions in PFIC1: ATP8B1 gene defect is associated with CFTR downregulation.
Demeilliers C; Jacquemin E; Barbu V; Mergey M; Paye F; Fouassier L; Chignard N; Housset C; Lomri NE
Hepatology; 2006 May; 43(5):1125-34. PubMed ID: 16628629
[TBL] [Abstract][Full Text] [Related]
13. Irinotecan-induced bile acid malabsorption is associated with down-regulation of ileal Asbt (Slc10a2) in mice.
Shi AX; Zhou Y; Zhang XY; Zhao YS; Qin HY; Wang YP; Wu XA
Eur J Pharm Sci; 2017 May; 102():220-229. PubMed ID: 28288854
[TBL] [Abstract][Full Text] [Related]
14. Abcg5/8 independent biliary cholesterol excretion in Atp8b1-deficient mice.
Groen A; Kunne C; Jongsma G; van den Oever K; Mok KS; Petruzzelli M; Vrins CL; Bull L; Paulusma CC; Oude Elferink RP
Gastroenterology; 2008 Jun; 134(7):2091-100. PubMed ID: 18466903
[TBL] [Abstract][Full Text] [Related]
15. Progressive familial intrahepatic cholestasis type 1.
Paulusma CC; Elferink RP; Jansen PL
Semin Liver Dis; 2010 May; 30(2):117-24. PubMed ID: 20422494
[TBL] [Abstract][Full Text] [Related]
16. Targeted deletion of the ileal bile acid transporter eliminates enterohepatic cycling of bile acids in mice.
Dawson PA; Haywood J; Craddock AL; Wilson M; Tietjen M; Kluckman K; Maeda N; Parks JS
J Biol Chem; 2003 Sep; 278(36):33920-7. PubMed ID: 12819193
[TBL] [Abstract][Full Text] [Related]
17. Folding defects in P-type ATP 8B1 associated with hereditary cholestasis are ameliorated by 4-phenylbutyrate.
van der Velden LM; Stapelbroek JM; Krieger E; van den Berghe PV; Berger R; Verhulst PM; Holthuis JC; Houwen RH; Klomp LW; van de Graaf SF
Hepatology; 2010 Jan; 51(1):286-96. PubMed ID: 19918981
[TBL] [Abstract][Full Text] [Related]
18. Importance of uncharged polar residues and proline in the proximal two-thirds (Pro107-Ser128) of the highly conserved region of mouse ileal Na+-dependent bile acid transporter, Slc10a2, in transport activity and cellular expression.
Saeki T; Sato K; Ito S; Ikeda K; Kanamoto R
BMC Physiol; 2013 Feb; 13():4. PubMed ID: 23374508
[TBL] [Abstract][Full Text] [Related]
19. Phospholipid flippase activities and substrate specificities of human type IV P-type ATPases localized to the plasma membrane.
Takatsu H; Tanaka G; Segawa K; Suzuki J; Nagata S; Nakayama K; Shin HW
J Biol Chem; 2014 Nov; 289(48):33543-56. PubMed ID: 25315773
[TBL] [Abstract][Full Text] [Related]
20. Apical sodium dependent bile acid transporter (ASBT, SLC10A2): a potential prodrug target.
Balakrishnan A; Polli JE
Mol Pharm; 2006; 3(3):223-30. PubMed ID: 16749855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
